7-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carbonitrile
95%
- Product Code: 50530
CAS:
1260387-11-8
| Molecular Weight: | 222.0400 g./mol | Molecular Formula: | C₈H₄BrN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18380878 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a bromo substituent and a cyano group, makes it a versatile building block for constructing complex heterocyclic compounds. It is particularly valuable in the design of potential drug candidates targeting specific enzymes or receptors, such as kinase inhibitors, which are crucial in cancer therapy. Additionally, its pyrrolopyridine core is often explored for its potential in developing treatments for neurological disorders and inflammatory diseases. The compound’s reactivity allows for further functionalization, enabling researchers to optimize drug-like properties such as potency, selectivity, and bioavailability.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $591.36 |
+
-
|
7-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carbonitrile
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a bromo substituent and a cyano group, makes it a versatile building block for constructing complex heterocyclic compounds. It is particularly valuable in the design of potential drug candidates targeting specific enzymes or receptors, such as kinase inhibitors, which are crucial in cancer therapy. Additionally, its pyrrolopyridine core is often explored for its potential in developing treatments for neurological disorders and inflammatory diseases. The compound’s reactivity allows for further functionalization, enabling researchers to optimize drug-like properties such as potency, selectivity, and bioavailability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :